Aduro Clean Technologies Presents at CEM Scottsdale Capital Event
April 11, 2023 07:00 ET
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, April 11, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Clean Technologies Announces Participation in Key Industry Conferences
February 16, 2023 07:00 ET
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Announces Grant of Stock Options and RSUs
December 29, 2022 20:30 ET
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Announces Stock Option Grants
June 20, 2022 19:32 ET
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, June 20, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Biotech, Inc. (Nasdaq: ADRO) to Ring The Nasdaq Stock Market Opening Bell
March 27, 2017 10:00 ET
|
NASDAQ, Inc.
ADVISORY, March 27, 2017 (GLOBE NEWSWIRE) -- What:Aduro Biotech, Inc. (Nasdaq:ADRO), an immunotherapy company focused on the discovery, development and commercialization of therapies that...
Aduro Biotech Appoints Liana Wu as Vice President of Commercial
June 02, 2015 08:00 ET
|
Chinook Therapeutics, Inc.
BERKELEY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Liana Wu has joined the company as vice president, commercial. Ms. Wu, a commercial leader...
Aduro Biotech Announces ASCO Presentation of Encouraging Data From Ongoing Phase 1b Clinical Trial of Its Immunotherapy for the Treatment of Mesothelioma
June 01, 2015 09:00 ET
|
Chinook Therapeutics, Inc.
BERKELEY, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its...
Aduro Biotech Announces First Quarter 2015 Financial Results
May 28, 2015 16:00 ET
|
Chinook Therapeutics, Inc.
Established major $750M collaboration with Novartis for STING in oncology
Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...